6Barohn RJ. Chronic inflammatory dernyelinating polyradiculoneuropathy, clinical characteristics, course and recommendations for diagnostic criterria. Arch Neurol, 1989, 46:878.
7Ad Hoc subcommittee of the American academy of Neurology AIDS Task Force (D. R. Cornblath, Chairman, Johns Hopkins, MD; A.K. Asbury, University of Pennsylvania, PA;J. W. Albers, University of Michigan, Ann Arbor, MI;T. E. Feasby and A. F. Hahn,University of Western Ontario, london, ON, Canada, et al). Research criteria for the diagnosis of chronic inflamatory demylinating polyradiculoneuropathy (CIDP). Neurol, 1991, 41 : 617.
8Gorson KC, Allam G, Ropper AH. Chronic inflammatory dernyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monclonal garnnopathy.Neurology, 1997, 48:321.
9Maimone D, Annunziata P, Simone IL, et al. Imerleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculonruropathy. N Engl J Med, 1999, 32:1182.
10Visser LH, Van-der Meche FG, Van Doom PA, et al. A subgroup with specific clinical , electrodiagnostic and laboratory features.Brain, 1995, 118;841.
